Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.
Sleep apnea, a condition that disrupts breathing during sleep, affects millions of people worldwide, especially adults over ...
“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...
Poor sleep hygiene can lead to negative health outcomes, but what exactly is sleep hygiene and how can you improve it?
A recent study has found a surprising connection between sleep-related breathing problems and changes in the brain. Published ...
According to the Centers for Disease Control and Prevention, roughly one in three adults in the U.S. don’t get enough rest or sleep every day. Meanwhile, an estimated 50 million to 70 million people ...
Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, ...
On Dec. 20, the FDA announced that the agency has approved Eli Lilly's Zepbound (tirzepatide) to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity. The drug is to be ...
The US Food and Drug Administration (FDA) has approved the obesity treatment tirzepatide (Zepbound, Eli Lilly) for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity.